Pharmaceutical giant Pfizer Inc. has agreed to pay $60 million as part of a settlement to resolve false claims allegations relating to improper physician payments by one of its subsidiaries, according to a Department of Justice (DOJ) statement. The DOJ said that between March 2020 and September 2022, Pfizer subsidiary Biohaven Pharmaceuticals violated the federal False Claims Act by providing speaker honoraria and meals at high-end restaurants to doctors, to induce them to prescribe Nurtec ODT, a migraine drug, more often. Some speaker programs were attended multiple times by the same doctors, resulting in no educational benefit, or attended by doctors’ spouses, family members, and colleagues who had no educational need to be there, the department added. Click here to read more